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The type 1 diabetes autoantigen ICA512/IA-2/RPTPN is a receptor protein tyrosine phosphatase of the insulin secretory granules
(SGs) which regulates the size of granule stores, possibly via cleavage/signaling of its cytosolic tail. The role of its extracellular
region remains unknown. Structural studies indicated that b2- orb4-strands in the mature ectodomain (ME ICA512) form
dimers in vitro. Here we show that ME ICA512 prompts proICA512 dimerization in the endoplasmic reticulum. Perturbation of
ME ICA512b2-strand N-glycosylation upon S508A replacement allows for proICA512 dimerization,O-glycosylation, targeting
to granules, and conversion, which are instead precluded upon G553D replacement in theME ICA512 b4-strand. S508A/G553D
and N506A/G553D double mutants dimerize but remain in the endoplasmic reticulum. Removal of the N-terminal fragment
(ICA512-NTF) precedingME ICA512 allows an ICA512-DNTF G553Dmutant to exit the endoplasmic reticulum, and ICA512-
DNTF is constitutively delivered to the cell surface. The signal for SG sorting is located within the NTF RESP18 homology do-
main (RESP18-HD), whereas soluble NTF is retained in the endoplasmic reticulum. Hence, we propose that the ME ICA512 b2-
strand fosters proICA512 dimerization until NTF prevents N506 glycosylation. Removal of this constraint allows for proICA512
b4-strand-induced dimerization, exit from the endoplasmic reticulum,O-glycosylation, and RESP18-HD-mediated targeting to
granules.
Receptor protein tyrosine phosphatases (RPTPs) form a largefamily of transmembrane proteins which counteract protein
tyrosine kinases and are therefore involved in many signaling
pathways. Dimerization of RPTPs is regarded as a main mecha-
nism to regulate their constitutive intracellular phosphatase activ-
ity. The contributions of extracellular, transmembrane, and cyto-
plasmic PTP regions to dimerization vary among different RPTPs
(1–4).
The extracellular domains of RPTPs can promote receptor
dimerization in several ways. As for receptor protein tyrosine ki-
nases, RPTP oligomerization and clustering can be induced upon
heterophilic binding to extracellular ligands. RPTPs for which
such a mechanism has been demonstrated include the type I RPTP
CD45/RPTPC, the type IIa protein RPTPs, the type III protein
RPTPb, and the type V protein RPTPz (5). In the case of CD45
and RPTPb, changes in glycosylation pattern, including O-glyco-
sylation, were shown to modulate their binding to galectin-1, con-
ceivably increasing clustering and affecting phosphatase activity
(6, 7). Homophilic interactions among ectodomains of RPTPs in
the same or apposing cells, as is the case for the type IIb proteins
RPTPm and RPTPk and the type IV protein RPTPa, likely repre-
sent another mechanism for inducing receptor oligomerization
and regulating phosphatase activity (8–10).
The type VII RPTP ICA512/IA-2/PTPRN and its homologue
phogrin/IA-2b/PTPRN2 are “pseudophosphatases” with a large
ectodomain followed by a transmembrane region and a single
catalytically inactive PTP domain (11, 12). They are expressed
mainly in neuropeptidergic neurons and peptide-secreting endo-
crine cells, including insulin-producing pancreatic b-cells, where
they are enriched in secretory granules (SGs) (13, 14). Upon ex-
pression inEscherichia coli, the transmembrane regions of phogrin
and ICA512 showed only weak or no ability to interact (2). On the
other hand, in transfected fibroblasts, the cytosolic juxtamem-
brane and PTP domains of ICA512 and phogrin were shown to
form homodimers as well as heterodimers with each other and
with the PTP domains of other conventional RPTPs, possibly in-
hibiting their phosphatase activity (15). In insulinoma cells, ho-
modimerization of the ICA512 PTP domain was found to disrupt
the interaction of the latter with the cortical actin cytoskeleton,
thereby affecting insulin SG dynamics and exocytosis (16).
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Recent structural studies of the recombinant membrane-prox-
imal mature ectodomain of ICA512 (ME ICA512/IA-2), which
results from cleavage of proICA512 by prohormone convertases
during SG maturation (13, 17), showed that this region readily
adopted various dimeric assemblies both in the protein crystals
and in solution (18, 19). In contrast, the corresponding recombi-
nant mature ectodomain of phogrin, despite its structural similar-
ity to ICA512 (20, 21), was found to fold as a monomer in solution
(20, 21). In this study, therefore, we investigated the ability of ME
ICA512 to induce receptor homodimerization in insulin-produc-
ing cells.
MATERIALS AND METHODS
Generation of ICA512 constructs and site-directed mutagenesis.
pEGFP-N1 constructs encoding full-length human ICA512 (amino acids
1 to 979), an ICA512 N-terminal fragment (NTF) (amino acids 35 to 446),
ICA512DNTF (amino acids 449 to 979), the ICA512 regulated endocrine-
specific protein 18 homology domain (RESP18-HD) (amino acids 35 to
131), or ME ICA512 (amino acids 449 to 575) were fused at their C termini
to green fluorescent protein (GFP) or a hemagglutinin (HA) epitope tag.
These constructs included either the native signal peptide or that of CD33,
while an 11-mer linker was placed between ME ICA512 and GFP. Con-
ventional cloning strategies were also used to generate ICA512-NTF or a
secretory GFP by inclusion of the CD33 signal peptide at the N terminus.
Site-directed mutagenesis using these constructs as templates was per-
formed with a QuikChange kit (Stratagene). All constructs and mutations
were verified by sequencing.
Antibodies against ICA512-NTF,ME ICA512, and ICA512 CT.Mouse
monoclonal antibodies directed against a recombinant fusion protein be-
tween glutathione S-transferase (GST) and amino acids 389 to 575 (anti-
ectodomain) or amino acids 935 to 974 (anti-ICA512 cytoplasmic tail
[CT]) of human ICA512 were generated in the Antibody Facility at the
Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG;
Dresden, Germany). The ectodomain antibodies were further selected for
recognition of an epitope within amino acids 389 to 446 of the NTF (anti-
ICA512 NTF Ab) or amino acids 449 to 575 of ME ICA512 (anti-ME
ICA512 Ab) by using a MesoScale Discovery platform and by Western
blotting against ICA512-NTF-GFP, ICA512-GFP DNTF, and GST.
Culture and transfection of insulinoma INS-1 cells. Rat INS-1 cells
were grown in RPMI 1640 medium as described previously (22). Cells
were split every 4 days, plated onto coverslips on 35-mm dishes (Costar),
and transfected for 3 days, after with plasmid DNA was diluted into Cy-
toporation medium by use of a Cyto Pulse electroporator (Cyto Pulse
Sciences, Inc.). Four days after transfection, cells were preincubated for 1
h in resting buffer (5 mM KCl, 120 mM NaCl, 24 mM NaHCO3, 1 mM
MgCl2, 2 mM CaCl2, 1 mg/ml ovalbumin, 5 mM HEPES, pH 7.5) and then
kept either at rest or in stimulation buffer (25 mM glucose [high glucose
{HG}] and 55 mM KCl [high K1 {HK}] in 70 mM NaCl, 24 mM NaHCO3,
1 mM MgCl2, 2 mM CaCl2, 1 mg/ml ovalbumin, and 5 mM HEPES, pH
7.5) for an additional 2 h. In some instances, 30mM calpeptin or MG-115
(Calbiochem) was added to the stimulation buffer. After 2 h of incuba-
tion, cells were washed twice with ice-cold phosphate-buffered saline
(PBS) and harvested in ice-cold lysis buffer (20 mM Tris-Cl, pH 8.0, 140
mM NaCl, 1 mM EDTA, 1 mM Triton X-100, and 1% protease inhibitor
cocktail [Sigma]). Cell lysates were centrifuged at 4°C and 12,000 rpm for
5 min in an Eppendorf 5415C centrifuge. The precleared soluble protein
fraction was separated from the pellet and prepared in SDS-PAGE sample
buffer for Western blotting.
Immunoprecipitation (IP). Equal amounts of cell lysates were mixed
with 20 ml (1/10 [vol/vol]) protein G-Sepharose beads (GE Healthcare)
and incubated on a rotating wheel at 4°C for 30 min to preclear the lysates
of the IgG-bound protein fraction. The lysates were centrifuged at 2,000
rpm for 3 min in an Eppendorf centrifuge, and the pellets of beads were
removed. Goat anti-GFP antibodies (MPI-CBG, Dresden, Germany) or
IgG from goat serum (Sigma) (1:100 dilution) was then incubated with
the precleared lysates overnight prior to the addition of 20 ml (1/10 [vol/
vol]) protein G-Sepharose beads. The lysates were centrifuged at 2,000
rpm for 3 min, and the soluble fraction was removed. The beads were
washed twice with PBS, centrifuged as described above, and resuspended
in SDS-PAGE sample buffer for Western blotting.
Enzymatic deglycosylation assays. INS-1 cells transfected for expres-
sion of different ICA512 variants or mouse or human islet cells were
incubated in resting or stimulation buffer for 2 h. Cells were lysed as
described above and incubated in denaturation buffer (New England Bio-
Labs) at 95°C for 5 min. The denatured samples of the cell lysates were
then incubated with peptide-N-glycosidase F (PNGase F), endoglycosi-
dase H orO-glycosidases, endo-a-N-acetylgalactosaminidase, and neura-
midase in 13 reaction buffer (New England BioLabs) at 37°C for 3 h.
Glycosylated fetuin from fetal calf serum (Sigma) was used as a control to
confirm the performance of glycosidases. Nontreated and enzyme-treated
cell lysates were prepared in SDS-PAGE sample buffer for Western blot-
ting.
Western blotting. Cell lysates and IPs in SDS-PAGE sample buffer
were heated to 95°C for 5 min and then subjected to SDS-PAGE and
Western blotting. The following primary antibodies were employed:
mouse monoclonal anti-GFP antibody (632381; Clontech), mouse anti-
ICA512 antibody HM-1 (23), mouse anti-g-tubulin antibody (T6557;
Sigma), and rabbit anti-HA antibody (ab9110; Abcam). Primary antibod-
ies were detected with horseradish peroxidase (HRP)-conjugated goat
anti-mouse or anti-rabbit IgG (Bio-Rad) followed by addition of sub-
strates for chemiluminescence (Thermo Scientific, Pierce Biotechnology),
using an LAS-3000 imaging system (Fuji). Black dividing lines in figures
indicate cutting of the same or different Western blots or their groupings.
Immunostaining and confocal microscopy. INS-1 cells transfected
for the expression of different ICA512 variants and grown on coverslips
on 35-mm dishes for 4 days posttransfection were incubated in resting or
stimulation buffer as described above, rinsed 3 times in PBS, and fixed
with 4% paraformaldehyde. After aldehyde quenching and permeabiliza-
tion (200 mM glycine, 0.1% Triton X-100 in PBS) for 20 min, cells were
incubated in blocking buffer (0.2% gelatin, 0.5% albumin in PBS) for 1 h
and then in blocking buffer with guinea pig anti-insulin antibody
(ab7842; Abcam) or rabbit anticalnexin antibody (C4731; Sigma) at 4°C
overnight. Next, cells were washed 5 times with PBS and then incubated in
blocking buffer with Alexa Fluor 568-conjugated goat anti-guinea pig or
anti-rabbit IgG (Molecular Probes) for 2 h at room temperature. After
additional washing 5 times with PBS, immunolabeled coverslips were
mounted onto slides with Mowiol.
INS-1 live-cell staining with the endoplasmic reticulum (ER) tracker
red dye (glibenclamide BODIPYTR; Molecular Probes) was done accord-
ing to the manufacturer’s protocol. ICA512 mature ectodomain- or cyto-
solic domain-specific antibodies (see above), the anti-ME ICA512 anti-
body, or the anti-ICA512 CT antibody was incubated with living INS-1
cells to assess ICA512 extracellular domain exposure at the cell surface.
Images of labeled cells were acquired with an Olympus FluoView-1000
laser scanning confocal microscope equipped with a 603 PlanoApo
OLSM lens (numerical aperture [NA]5 1.10).
Cell sorting. Four days after transfection with ICA512-GFP, ICA512-
GFP G553D, or ICA512-GFP N506A/N524A, cells were detached by tryp-
sin digestion and resuspended in 13 PBS, 25 mM HEPES (pH 7.0), 1 mM
EDTA, and 1% albumin. The cell suspension was filtered through cell
strainer caps into 5-ml round-bottom Falcon tubes (Corning) prior to
sorting for GFP expression with a Becton Dickinson BD FACS Aria II flow
cytometer. Sorted cells expressing the ICA512-GFP variants were cultured
in 24-mm culture dishes (Costar) with RPMI 1640 medium.
Insulin gene expression, contents, and secretion.After 2 days in cul-
ture, the total RNA of 1 3 105 cells sorted for the expression of each
ICA512-GFP variant was purified with a Qiagen RNeasy kit and used as an
RNA template for first-strand cDNA synthesis with SuperScript II reverse
transcriptase (Invitrogen) and an oligo(dT) primer. Levels of insulin
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mRNA were analyzed by quantitative real-time PCR with a GoTaq quan-
titative PCR kit (Promega) and an MX4000 thermocycler (Stratagene).
b-Actin mRNA was amplified in parallel for normalization of the insulin
mRNA levels in the individual samples. Alternatively, 3 3 105 ICA512-
GFP1 sorted cells were switched to resting buffer for preincubation for 1
h and then to resting or stimulation buffer for an additional 2 h before
being harvested for analyses of proinsulin/insulin content and insulin
secretion under static conditions by use of a rat/mouse proinsulin/rat
insulin enzyme-linked immunosorbent assay (ELISA) (Mercodia).
Statistical analysis. All data are representative of three or more inde-
pendent experiments, with the exception of the analysis of human islet
cells, which was performed two times. Statistical significance was assessed
with Student’s t test or analysis of variance (ANOVA).
RESULTS
proICA512 dimerizes in INS-1 cells. ME ICA512 encompasses
amino acids 449 to 575 of human ICA512 (Fig. 1A). The X-ray
structure of recombinant ME ICA512 (Fig. 1B) (18), encompass-
ing amino acids 468 to 558, revealed that this region displays a
ferredoxin-like fold related to the SEA (sea urchin sperm protein,
enterokinase, agrin) domain, which is known to promote oli-
godimerization (24–28). Accordingly, both crystallized (18) and
soluble (19) versions of ME ICA512 form dimers resulting from
the antiparallel pairing of b2-b2 or b4-b4 strands (Fig. 1B) (19).
To verify the occurrence of ICA512 dimers in insulin-produc-
ing cells, full-length ICA512 constructs differentially tagged at the
C terminus with GFP (ICA512-GFP) or an HA epitope (ICA512-
HA) (Fig. 2A) were transiently expressed alone or together in rat
insulinoma INS-1 cells. Consistent with previous findings (29,
30), the mature transmembrane fragments (TMF) of ICA512-
GFP (ICA512-TMF-GFP; ;100 kDa) and ICA512-HA (ICA512-
TMF-HA; ;75 kDa) were the major ICA512 species detected in
cell lysates of resting (R) INS-1 cells (Fig. 2A). In cells stimulated
(S) with 25 mM glucose, with or without 55 mM KCl, the respec-
tive proICA512 species became the most prominent species, while
the levels of the corresponding ICA512-TMF, which undergoes
calpain-mediated cleavage upon SG exocytosis (29, 30), were
drastically reduced. Stimulation with 55 mM KCl alone, which
prompts SG exocytosis, also reduced the levels of ICA512-TMF
but barely upregulated those of proICA512. The detection of mul-
tiple proICA512 species reflects the different degrees of glycosyla-
tion of the protein during its maturation along the secretory path-
way prior to cleavage and conversion into ICA512-TMF. Notably,
in cells stimulated with 55 mM KCl alone, the major proICA512
form migrated faster than the proICA512 species detected in cells
concomitantly exposed to high glucose. This discrepancy conceiv-
ably reflects differences in the efficiency of proICA512 N-glycosy-
lation in the ER depending on the glucose level.
proICA512-HA and ICA512-TMF-HA were readily detect-
able, albeit at lower levels when coexpressed with ICA512-GFP
(Fig. 2B). Immunoprecipitation with anti-GFP antibodies led to
the recovery of ICA512-TMF-GFP or proICA512-GFP from rest-
ing or stimulated cells, respectively (Fig. 2C, top panel). Coimmu-
noprecipitation of proICA512-HA but not ICA512-TMF-HA
suggests that proICA512 but not ICA512-TMF forms dimers (Fig.
2C, bottom panel). Neither ICA512-GFP nor ICA512-HA coim-
munoprecipitated with control IgGs.
ME ICA512 mediates the dimerization of proICA512 in
INS-1 cells. Previous studies in vitro and in transfected INS-1 cells
indicated that the intracellular PTP domain of ICA512 can
dimerize (15, 16). To verify whether ME ICA512 could account
for proICA512 dimerization independently of the cytoplasmic do-
main, INS-1 cells were transfected with ICA512-HA either alone
or in combination with soluble ME ICA512-GFP (Fig. 2D, left
panel). The slowest electrophoretic species of ME ICA512 was
upregulated in stimulated cells and migrated at the expected size
of ca. 50 kDa, also taking into account its N-glycosylation. The
fastest-migrating species corresponded to the nonglycosylated
form of ME ICA512-GFP (also see below and Fig. 5D). Immuno-
precipitation of ME ICA512-GFP led to the specific recovery of
proICA512-HA from both resting and stimulated cells (Fig. 2D,
right panel). Hence, consistent with in vitro structural and bio-
chemical analyses (18, 19), ME ICA512 was sufficient to induce
the dimerization of proICA512 in INS-1 cells.
Lack ofN-glycosylation or perturbation of theb2-b2 associ-
ation interface of ME ICA512 does not preclude SG sorting and
conversion of ICA512. An electrophoretic mobility shift of
ICA512 upon digestion with PNGase F indicated that the protein
is N-glycosylated (17) (also see below and Fig. 4C and 8D).
ICA512 contains only two consensus sites for N-glycosylation, at
N506 and N524, both within ME ICA512 (Fig. 1A and B). N506 is
located in the b2-strand (Fig. 1B), a critical structural element for
b2-b2 dimerization (19). The consensus sequence for N506 gly-
cosylation includes S508, which was shown to mediate b2-b2
dimerization of ME ICA512 in vitro (19). N524 is instead remote
from the identified dimerization interfaces (Fig. 1B).
To verify the glycosylation of both N506 and N524, INS-1 cells
were independently transfected with the single mutants ICA512-
GFP N506A, ICA512-GFP S508A, and ICA512-GFP N524A or the
double mutant ICA512-GFP N506A/N524A. ICA512-TMF of all
ICA512-GFP mutants, as detected with the anti-GFP or anti-
ICA512 HM-1 antibody, displayed a faster electrophoretic mobil-
ity than that of wild-type ICA512 in resting cells (Fig. 3A). A sim-
ilar behavior was observed for the corresponding proICA512-GFP
species in resting and stimulated cells (Fig. 3A and B). Thus, both
N506 and N524 are glycosylated. The expression of proICA512-GFP
N506A/N524A was significantly higher than that of ICA512-GFP
or single N-glycosylation ICA512-GFP mutants (Fig. 3C), con-
ceivably due to its delayed folding, traffic, and conversion. Lack of
N-glycosylation, however, did not prevent the sorting of ICA512-
GFP N506A/N524A into SGs, as indicated by its colocalization
with insulin at the cell periphery of INS-1 cells, similar to that of
ICA512-GFP (Fig. 3D). Notably, ICA512-GFP S508A, for which
b2-b2 dimerization should be perturbed (19), was also sorted into
SGs (Fig. 3D).
The total level of insulin mRNA in ICA512-GFP N506A/
N524A1 sorted cells was not significantly changed compared to
that in ICA512-GFP1 sorted cells (Fig. 3E). Likewise, in ICA512-
GFP N506A/N524A1 sorted cells, the proinsulin (Fig. 3F) and
insulin (Fig. 3G) contents and the fractional stimulated insulin
secretion level (Fig. 3H) were not significantly reduced compared
to those in ICA512-GFP1 sorted cells.
Perturbation of the ME ICA512 b4-b4 association interface
precludes SG sorting and conversion of ICA512. The replace-
ment of G553, which sterically and electrostatically hindersb4-b4
dimerization (19), profoundly altered the maturation and stabil-
ity of ICA512, in contrast to the case for the replacement of N506
or S508 in the b2-b2 interface. Specifically, the expression of
ICA512-TMF-GFP G553D was dramatically reduced (Fig. 4A and
B, lanes 4). This was also the case upon cell treatment with the
proteasome inhibitor MG-115 (Fig. 4A, lane 6) or calpeptin
Torkko et al.
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FIG 1 Sequence of the ICA512 extracellular domain and model of ME ICA512 dimerization through b2-b2 and b4-b4 interfaces. (A) Primary amino acid
sequence of human (Hs) ICA512 extracellular domain (amino acid residues 1 to 575), including the signal peptide (SP) (residues 1 to 34), the RESP18 homology
domain (RESP18-HD) (residues 35 to 133), as a part of the N-terminal fragment (NTF) (residues 35 to 448), and the mature ectodomain (ME) (residues 449 to
575 [in bold]). Residues in a-helices and b-strands of ME ICA512, as resolved in reference 18, are highlighted in orange and yellow, respectively. The
N-glycosylation sites N506 and N524 are indicated in red, and cleavage sites for protein convertases (KR [residues 132 and 133], KK [residues 386 and 387], and
KK [residues 447 and 448]) are underlined. Clustered cysteines within the RESP18-HD (C40, C47, C53, and C62) are indicated in italics, while threonines and
serines predicted as putative O-glycosylation sites are indicated with asterisks. Critical residues for b2-b2 (S508)- or b4-b4 (G553)-mediated dimerization of
recombinant ME ICA512 in vitro are shown in purple. (B) Modeledb2-b2 (left) andb4-b4 (right) ME ICA512 dimers (symmetry axes are shown by dotted lines)
as resolved by X-ray crystallography (18). The color code for the relevant residues and secondary structures is the same as that described for panel A. The
schematic drawing of ICA512 below the models shows the extracellular domain regions described for panel A, followed by the transmembrane (TM) region and
the cytosolic PTP domain. The arrow and arrowhead indicate the cleavage site for conversion of proICA512 into ICA512-TMF and the more distal cleavage site
for calpain in the cytoplasmic domain of ICA512-TMF, respectively.
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FIG 2 ME ICA512 is sufficient for dimerization of proICA512 in INS-1 cells. (A) Schematic drawings of ICA512-GFP and ICA512-HA and their detection by
immunoblotting with mouse anti-GFP or rabbit anti-HA antibody in lysates of singly transfected INS-1 cells. The arrows indicate the cleavage site for conversion
of proICA512 into ICA512-TMF, while the arrowheads indicate the more distal calpain cleavage site in the cytoplasmic domain of ICA512-TMF. Prior to lysis,
cells were either kept at rest (R) in 0 mM glucose and 5 mM KCl or stimulated (S) for 2 h with either 55 mM KCl (high K1), 25 mM glucose (high glucose), or
both (high glucose and high K1 [HGHK]) (n$ 3). (B) Immunoblotting for HA or GFP in lysates of INS-1 cells transfected with ICA512-HA alone or together
Torkko et al.
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(Fig. 4B, lane 6), which prevents the calpain-mediated cleavage of
ICA512-TMF, and thus its disappearance (Fig. 4B, lane 3). These
observations suggested that the G553D replacement prevents the
conversion of proICA512-GFP into ICA512-TMF-GFP. Con-
versely, expression of ICA512-GFP G553D correlated with the
enrichment of proteolytic fragments, mostly in resting cells (Fig.
4A and B, lanes 1 and 4) but also in stimulated cells treated with
MG-115 (Fig. 4A, lanes 3 and 6) or calpeptin (Fig. 4B, lanes 3 and
6). Notably, proICA512-GFP G553D appeared as a single band
with an electrophoretic mobility comparable to that of the fastest-
migrating species of proICA512-GFP (Fig. 4A and B, lanes 2 ver-
sus lanes 5). Sensitivity to PNGase F treatment indicated that this
phenotype is not attributed to a lack of N-glycosylation (Fig. 4C).
Analysis by confocal microscopy further indicated that ICA512-
GFP G553D (Fig. 4D, left panels), unlike ICA512-GFP and
ICA512-GFP S508A (Fig. 3D), did not colocalize with insulin (Fig.
4D, left panels) but was dispersed throughout the cytoplasm, with
a reticular pattern resembling that of the ER tracker red dye (Fig.
4D, right panels). These data suggested that ICA512-GFP G553D
is retained within the ER.
In ICA512-GFP G553D1 sorted cells, similar to ICA512-GFP
N506A/N524A1 sorted cells (see above and Fig. 3), the total level
of insulin mRNA was not changed (Fig. 4E). The proinsulin (Fig.
4F) and insulin (Fig. 4G) contents and the fractional stimulated
insulin release level (Fig. 4H) were also not significantly changed
relative to those of ICA512-GFP1 sorted cells.
ICA512 is O-glycosylated. ME ICA512 possesses a SEA do-
main fold, which is present in some mucins and other membrane
proteins. SEA domain-containing proteins are commonly exten-
sively O-glycosylated near this domain, possibly to hinder its prote-
olysis (25, 27, 28). We therefore wondered whether ICA512 is also
O-glycosylated and whether this modification, which occurs mainly
in the Golgi apparatus, would be affected by the G553D replacement.
O-Glycosidase treatment increased the electrophoretic mobil-
ity of theO-glycosylated control protein fetuin (Fig. 5A), as well as
that of ICA512-TMF-GFP (Fig. 5B, lane 1 versus lane 2), in ex-
tracts of resting cells. De-O-glycosylation of lysates from stimu-
lated cells led to the almost complete disappearance of the slowest-
migrating species of proICA512-GFP (Fig. 5B, lane 3 versus lane
4). A comparable mobility shift of ICA512-TMF was observed
uponO-glycosidase treatment of lysates of mouse and human islet
cells (Fig. 5C), thus indicating that this modification, similar to
N-glycosylation (17), also occurs in nontransformed ICA512-ex-
pressing tissues. proICA512-GFP N506A (Fig. 5B, lane 5 versus
lane 6 and lane 7 versus lane 8) and proICA512-GFP S508A (Fig.
5B, lane 9 versus lane 10 and lane 11 versus lane 12), as well as the
corresponding ICA512-TMF forms (Fig. 5B, lane 5 versus lane 6
and lane 9 versus lane 10), were also O-glycosidase sensitive. Con-
versely, the single proICA512-GFP G553D species was O-glycosi-
dase insensitive (Fig. 5B, lane 15 versus lane 16), consistent with its
retention in the ER (Fig. 4D).
Relevanceof theNTFdomain forO-glycosylation andexport
of proICA512 from the ER. Soluble ME ICA512-GFP, ME
ICA512-GFP S508A, and ME ICA512-GFP G553D (Fig. 5D, lanes
1, 5, and 9) were reduced to a single band upon treatment with the
N-glycosidase endoglycosidase H (Fig. 5D, lanes 2, 6, and 10) or
PNGase F (Fig. 5D, lanes 3, 7, and 11) but were insensitive to
O-glycosidases (Fig. 5D, lanes 4, 8, and 12). Thus, multiple ME
ICA512-GFP species result from N-glycosylation alone. However,
the endoglycosidase H sensitivity of all these ME ICA512 variants
further indicated that these retain the high-mannose-structure
N-oligosaccharide chains, i.e., they are not exported from the ER.
Indeed, confocal microscopy indicated that ME ICA512-GFP or
its G553D variant was found to accumulate in the ER (Fig. 5E),
concurrent with the lack of O-glycosylation.
Sequence analysis of ICA512 with NetOGlyc 3.1 (31) pointed
to serines and threonines clustered within amino acid residues 400
to 440, i.e., in the NTF domain (13, 17), preceding ME ICA512, as
the most likely sites for O-glycosylation (Fig. 1A). Nonetheless,
the deletion mutant ICA512-GFP DNTF, which lacks amino acid
residues 35 to 448 (Fig. 1A), i.e., the entire NTF domain, as well as
the corresponding ICA512-GFP DNTF S508A and ICA512-GFP
DNTF G553D mutants, was both PNGase F (Fig. 5F, lanes 3, 7, and
11) and O-glycosidase (Fig. 5F, lanes 4, 8, and 12) sensitive. No-
tably, ICA512-GFP DNTF and ICA512-GFP DNTF G553D dis-
played comparably lower electrophoretic mobilities than that of
ICA512-GFPDNTF S508A, suggesting their similar glycosylations
at N506 and N524. Moreover, ICA512-GFPDNTF G553D, similar
to all other constructs lacking the NTF domain, was endoglycosi-
dase H resistant (Fig. 5F, lanes 2, 6, and 10) and, unlike ICA512-
GFP G553D, did not undergo extensive proteolysis. Evidence that
proICA512 mutants lacking the NTF domain can fold and exit
from the ER even if the ME ICA512 b4-b4 dimerization interface
is perturbed suggests that this region contains information for
retention of unfolded proICA512 in the ER.
ICA512-NTF is required for targeting of proICA512 to SGs.
To further verify the progression of ICA512-GFPDNTF along the
secretory pathway, we imaged its localization in nonpermeabi-
lized resting (Fig. 6A and B) or stimulated (Fig. 6C) INS-1 cells
kept at 4°C to block endocytosis. Both ICA512-GFP and ICA512-
GFP DNTF, as detected by GFP fluorescence, appeared to be en-
riched at the cell periphery (Fig. 6A to C). However, labeling with
a novel mouse anti-ME ICA512 antibody revealed that ICA512-
GFP DNTF, unlike ICA512-GFP, was exposed at the cell surface
even under resting conditions (Fig. 6A). As expected, the concom-
itant control labeling of resting cells for insulin, which, like
ICA512-GFP, should be confined mainly to SGs and not exposed
at the surface, was negative (Fig. 6A). Surface labeling with a
mouse anti-ICA512 CT antibody was also negative (Fig. 6B). Con-
versely, the anti-ME ICA512 antibody labeled the surfaces of both
ICA512-GFP- and ICA512-GFP DNTF-expressing stimulated
cells, albeit more prominently in the case of the latter cells (Fig.
6C). Thus, ICA512-GFP DNTF, unlike ICA512-GFP, is constitu-
tively targeted to the cell surface.
Immunoblotting with anti-GFP (Fig. 6D) or anti-ME ICA512
(Fig. 6E) antibody indicated that unlike ICA512-GFP (Fig. 6D and
with ICA512-GFP. Prior to lysis, the cells were either kept at rest (R) or stimulated (S) for 2 h with HGHK (n$ 3). For normalization, the same cell lysates were
also immunoblotted for g-tubulin. (C) Immunoblotting for HA or GFP in immunoprecipitates obtained using goat anti-GFP antibody or goat IgG from the
lysates shown in panel B (n$ 3). (D) Schematic drawing of ME ICA512-GFP and immunoblotting for HA or GFP in lysates and corresponding immunopre-
cipitates, obtained using goat anti-GFP antibody, from INS-1 cells transfected with ICA512-HA alone or together with ME ICA512-GFP. Prior to lysis, the cells
were kept at rest (R) or stimulated (S) for 2 h with HGHK (n$ 3). For normalization, the same cell lysates were also immunoblotted for g-tubulin.
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E, lane 1 versus lane 2), ICA512-GFPDNTF (Fig. 6D and E, lane 3
versus lane 4) was not susceptible to Ca21/calpain-dependent
cleavage upon stimulation of INS-1 cells. Hence, the NTF domain
is required not only to retain unfolded proICA512 in the ER but
also for targeting the latter to SGs, thus enabling the cleavage of
ICA512-TMF upon granule exocytosis (29, 30).
The RESP18 homology domain targets proICA512 to SGs.
The most N-terminal portion of ICA512-NTF corresponds to the
RESP18 homology domain (RESP18-HD) (32), which begins at
amino acid residue 35, following the signal peptide, and ends at a
putative cleavage site for protein convertases, between residues
133 and 134 (17) (Fig. 1A). Similar to RESP18 (32, 33), ICA512-
RESP18-HD is characterized by a cysteine-rich motif (Fig. 1A),
which may be relevant for sorting into SGs. In particular, other
characteristic neuroendocrine proteins, such as chromogranin B
and secretogranin II, have been shown to depend on disulfide-
bonded loops for their targeting to SGs (34–36).
Consistent with the enrichment of RESP18 in SGs (32, 33),
soluble ICA512-RESP18-HD-GFP also colocalized extensively
with insulin in SG-like structures (Fig. 7A), and its recovery in the
FIG 3 Perturbing N-glycosylation or the ME ICA512 b2-strand does not prevent ICA512 targeting to SGs. (A and B) Immunoblotting for GFP or ICA512 in
lysates of resting (A) or stimulated (B) INS-1 cells transfected with either wild-type (wt) ICA512-GFP or the N506A, N524A, N506A/N524A, or S508A mutant
(n$ 3). For normalization, the same cell lysates were also immunoblotted for g-tubulin. (C) Quantification by ANOVA of proICA512-GFP species (top) and
of the ratios of the corresponding proICA512-GFP/ICA512-TMF-GFP species (bottom). The mean6 standard error of the mean (SEM) for each ICA512 species
was normalized to that for g-tubulin in the same lysates. *, P, 0.005 (n5 3). (D) Confocal microscopy images of HGHK-stimulated INS-1 cells transfected with
ICA512-GFP or the corresponding N506A/N524A or S508A mutant (green) and immunostained for insulin (red) (n $ 3). Nuclei were labeled with DAPI
(4=,6-diamidino-2-phenylindole) (blue). Bars5 5mm. (E) Levels of insulin mRNA in ICA512-GFP wt and ICA512-GFP N506A/N524A sorted cells as measured
by reverse transcription-PCR (RT-PCR) and normalized for b-actin mRNA levels (n 5 3). Levels of proinsulin (F) and insulin (G) in ICA512-GFP wt and
ICA512-GFP N506A/N524A sorted cells kept at rest (R) or stimulated (S) for 2 h with HGHK were measured by ELISA (n5 3). (H) Insulin secretion measured
from ICA512-GFP wt and ICA512-GFP N506A/N524A sorted cells kept at rest (R) or stimulated (S) for 2 h with HGHK (n5 3).
FIG 4 Perturbing the ME ICA512 b4-strand impairs proICA512 stability and targeting to SGs. (A and B) Immunoblotting for GFP in lysates of resting (R) or
HGHK-stimulated (S) INS-1 cells transfected with ICA512-GFP or ICA512-GFP G553D and left untreated (2) or treated (1) with the protease inhibitor
MG-115 (A) or calpeptin (B) (n$ 3). For normalization, the same cell lysates were also immunoblotted for g-tubulin. (C) Immunoblotting for GFP in lysates
of HGHK-stimulated INS-1 cells transfected with ICA512-GFP or ICA512-GFP G553D and left untreated (2) or treated (1) with the N-glycosidase PNGase F
(n $ 3). (D) Confocal microscopy images of HGHK-stimulated INS-1 cells transfected with ICA512-GFP (top panels) or the corresponding G553D mutant
(bottom panels) and immunostained for insulin (red; left panels) or colabeled with ER tracker red dye (red; right panels) (n$ 3). Nuclei were labeled with DAPI
(in blue). Bars5 5 mm. (E) Insulin mRNA levels (n5 3). (F) Proinsulin levels (n5 3). (G) Insulin levels (n5 3). (H) Secreted insulin levels (n5 3).
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medium was enhanced upon stimulation of the cells (Fig. 7B).
Conversely, soluble ICA512-NTF-GFP, despite the inclusion of
RESP18-HD, displayed a diffuse ER-like pattern (Fig. 7C and D)
resembling that of the ER marker calnexin (Fig. 7D). A similar
expression pattern was observed for ICA512-NTF (Fig. 7F), as
detected with a novel antibody that recognizes human NTF but
not the equivalent domain of the endogenous rat protein (Fig. 7E,
right panel, lane 1 versus lane 2). These data exclude the possibility
that retention of soluble ICA512-NTF in the ER is secondary to its
misfolding upon fusion with GFP. Intriguingly, in cells expressing
soluble ICA512-NTF-GFP, insulin immunoreactivity was also
more diffuse, rather than being enriched in SGs as in cells express-
ing ICA512-RESP18-HD-GFP (Fig. 7A). Thus, RESP18-HD con-
tains information that is sufficient for SG targeting, while the re-
maining portion of ICA512-NTF exerts a dominant role in ER
retention, unless it is associated with the remaining C-terminal
transmembrane portion of the protein.
The ME ICA512 b4-b4 strand interface is involved in
dimerization. Finally, we investigated the occurrence of the main
dimerization modes identified in the X-ray structure of nonglyco-
sylated ME ICA512 by using cells (18, 19). The association
through a b2-b2 interface was tested by the S508A mutation,
FIG 5 ME ICA512 is O-glycosylated. (A) Ponceau S staining of recombinant fetuin left untreated (2) or treated (1) with O-glycosidases. (B) Immunoblotting
for GFP in lysates of resting (R) or HGHK-stimulated (S) INS-1 cells transfected with ICA512-GFP, ICA512-GFP N506A, ICA512-GFP S508A, or ICA512-GFP
G553D and left untreated (2) or treated (1) with O-glycosidases (n$ 3). (C) Immunoblotting for ICA512 in lysates of resting (R) or HGHK-stimulated (S)
mouse and human pancreatic islet cells left untreated (2) or treated (1) with O-glycosidases (for upper and lower panels, n5 3 and n5 2, respectively). For
normalization, the same lysates were also immunoblotted for g-tubulin. (D) Immunoblotting for GFP in lysates of HGHK-stimulated INS-1 cells transfected
with ME ICA512-GFP, ME ICA512-GFP S508A, or ME ICA512-GFP G553D and left untreated (2) or treated (1) with O-glycosidases, PNGase F, or
endoglycosidase H (n5 3). (E) Merged confocal microscopy images of INS-1 cells transfected with ME ICA512-GFP or ME ICA512-GFP G553D (green) and
colabeled with the ER tracker red dye (red) and DAPI (for nuclei; blue) (n5 3). Bars 5 10 mm. (F) Schematic drawing of ICA512-GFP DNTF and immuno-
blotting for GFP in lysates of HGHK-stimulated INS-1 cells transfected with ICA512-GFPDNTF, ICA512-GFPDNTF S508A, or ICA512-GFPDNTF G553D and
left untreated (2) or treated (1) with O-glycosidases, PNGase F, or endoglycosidase H (n5 3). Fetuin (A) and the ICA512-related protein fragments (B, C, and
F) sensitive to O-glycosidase treatment (1) are indicated by arrowheads.
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which impeded dimerization of recombinant nonglycosylated ME
ICA512 in vitro (albeit not in the crystal). The second dimerization
mode, through the b4-b4 interface, was tested by the G553D re-
placement, which is sterically incompatible with this mode (19).
ICA512-HA and ME ICA512-GFP variants with the symmetric
single or combined mutations were coexpressed in INS-1 cells, and
the lysates of the stimulated cells and the corresponding immunopre-
cipitates were analyzed by immunoblotting (Fig. 8A and B). While
symmetric replacement of S508 did not preclude the recovery of
proICA512-HA S508A with ME ICA512-GFP S508A (Fig. 8B, lane
9), the symmetric replacement of G553 prevented the coimmunopre-
cipitation of proICA512-HA G553D with ME ICA512-GFP G553D
(Fig. 8B, lane 10). The recovery of proICA512-HA mutants with the
corresponding ME ICA512-GFP variants was specific, as coimmu-
noprecipitations with control IgG were significantly less effective
than those with the anti-GFP antibody (Fig. 8B, lanes 13 to 18, and
C). These findings suggest that dimerization of proICA512 occurs
through b4-b4 interactions. Remarkably, however, the combined
S508A/G553D replacement was still permissive for ME ICA512
dimerization, although the recovered proICA512-HA S508A/
G553D variant displayed a faster electrophoretic mobility (Fig. 8B,
lane 11), consistent with a lack of N506 glycosylation. Hence, even
upon perturbation of the b4-b4 interface, dimerization may still
occur via the b2-b2 interaction, but only under conditions which
prevent/precede N506 glycosylation. Glycosylation, because of its
bulkiness, would impede the physical contact between b2-strands.
Consistent with this interpretation was the greater yield of coimmu-
noprecipitated proICA512-HA upon replacement of N506 rather
than S508 in combination with G553 (Fig. 8B, lane 12, and C).
According to the structural data, N506 is less critical than S508
for the establishment/retention of a b2-b2 dimer interface (19),
and thus for protein folding and stability, as corroborated by the
larger amount of proICA512-HA N506A/G553D than of
proICA512-HA S508A/G553D in the cell lysate (Fig. 8A, lane 6
versus lane 5). Notably, b2-b2 proICA512 dimers are retained
mainly in the ER, as shown in the specific case of proICA512-HA
S508A/G553D, which for the most part remained endoglycosidase
H sensitive (Fig. 8D, lower panel) and was not converted to the
corresponding mature ICA512-TMF species (Fig. 8D, upper
panel). Hence, preclusion of N506 glycosylation does not rescue
the replacement of G553, but it allows the detection of b2-b2
interface-mediated dimerization of ME ICA512, which under
normal conditions may represent only a transient state of the re-
ceptor. Once N506 glycosylation occurs, folding of the b4-b4 in-
terface would become critical for stabilization/dimerization of
proICA512 and for overcoming the dominant ER retention signal
within ICA512-NTF, thus enabling further progression of the
protein along the secretory pathway and its RESP18-HD-medi-
ated targeting to the SGs (Fig. 8E).
DISCUSSION
Dimerization of RPTPs has generally been found to occur at the
cell surface. This process is driven by the interaction of ligands
with the extracellular domain and can affect the phosphatase ac-
tivity of the cytoplasmic PTP domain. In the case of ICA512, how-
ever, no extracellular ligands have yet been identified. Its signaling
pathway also remains unclear, although the calpain-cleaved cyto-
solic fragment generated upon granule exocytosis has been sug-
gested to act as a retrograde signal to modulate insulin SG mobility
and biogenesis in relationship to the size and consumption of the
SG stores (16, 23, 30). In this work, we have begun to unravel some
of the functional properties of the ICA512 SG luminal/extracellu-
lar region.
Specifically, we showed that ME ICA512 is sufficient to pro-
FIG 6 NTF targets ICA512 to SGs. (A to C) Confocal microscopy images of resting (A and B) or HGHK-stimulated (C) INS-1 cells transfected with ICA512-GFP (top
panels; green) or ICA512-GFPDNTF (bottom panels; green). Live cells were incubated at 4°C with the mouse anti-ME ICA512 antibody (A and C), together with the
guinea pig anti-insulin antibody in panel A, or were incubated with the mouse anti-ICA512 CT antibody (B). After fixation, the binding of the primary antibodies to the
cell surface was detected by incubation with Alexa Fluor-conjugated anti-mouse (A to C) (red) or anti-guinea pig (A) (white) IgG. Merged images are additionally shown
for panels A and C. Bars5 10mm (n$ 3). (D and E) Immunoblotting for GFP (D) and ME ICA512 (E) in lysates of resting (R) or HGHK-stimulated (S) INS-1 cells
transfected with ICA512-GFP or ICA512-GFPDNTF (n$ 3). For normalization, the same lysates were also immunoblotted for g-tubulin.
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mote ICA512 dimerization in cells (Fig. 2D), as suggested by pre-
vious structural studies of the corresponding recombinant por-
tion of the receptor (18, 19). Notably, we detected dimers only of
proICA512, not ICA512-TMF (Fig. 2C and D), implying that mat-
uration of the protein resolves this interaction such that, in the
SGs, ICA512-TMF is present as a monomer. On the other hand,
we cannot exclude the possibility that in the granule lumen,
ICA512-TMF instead forms a heterodimer with soluble ICA512-
NTF generated from convertase-mediated cleavage of proICA512
between residues 448 and 449 (Fig. 1A). Repeated attempts to
coimmunoprecipitate ICA512-NTF with ICA512-TMF, however,
have been unsuccessful. Since ICA512-NTF contains two addi-
tional likely sites for convertase cleavage, between residues 133
and 134 and residues 387 and 388 (Fig. 1A), it is also possible that
two putative fragments resulting from these cleavages, of;28 kDa
and ;7 kDa, were not detected by SDS-PAGE and Coomassie
blue/silver staining, either being masked by the IgG light chain or
due to their small size. Other factors that may disrupt ME ICA512
dimers include posttranslational modifications occurring while
the protein transits from the ER to the SGs, the progressive in-
traluminal acidification of the Golgi and SG compartments,
and/or binding to other secretory proteins. Intriguingly, it has
been reported that phogrin/IA-2b interacts with carboxypepti-
dase E/H (37). Finally, we cannot rule out that ME ICA512 again
prompts homodimerization of ICA512-TMF once the latter is
transiently inserted into the plasma membrane upon granule ex-
ocytosis.
Our data suggest that dimerization of proICA512 occurs in the
ER. Supporting this conclusion is the fact that proICA512-GFP
G553D accumulates in the ER (Fig. 4D) and does not undergo
O-glycosylation (Fig. 5B), a posttranslational modification that
most commonly occurs in the Golgi apparatus. However,
ICA512-GFP DNTF G553D is endoglycosidase H resistant and
O-glycosylated (Fig. 5F). These findings, together with evidence
that soluble NTF accumulates instead in the ER (Fig. 7C, D, and
F), suggest that NTF contains an ER retention signal. In contrast,
soluble RESP18-HD-GFP, similar to its paralogue RESP18 (32, 33,
38), is targeted to the SGs (Fig. 7A) and released in a regulated
fashion from the cells (Fig. 7B). Accordingly, ICA512-GFP DNTF
is neither retained in the ER nor targeted to SGs but is constitu-
tively delivered to the cell surface (Fig. 6A to C). Intriguingly, in
cells overexpressing soluble NTF but not soluble RESP18-HD,
insulin immunoreactivity is also more diffuse and less granular
(Fig. 7C). Additional studies on the structures of ICA512-NTF
FIG 7 NTF contains information for both ER retention and SG targeting. (A) Schematic drawing of ICA512-RESP18-HD-GFP and confocal microscopy images of
resting INS-1 cells transfected with ICA512-RESP18-HD-GFP (green) and immunostained for insulin (red) (n$3). Nuclei were labeled with DAPI (blue). Bars55mm.
(B) Immunoblotting for GFP in lysates (left) or immunoprecipitates, obtained with a different, goat anti-GFP antibody from the incubation media (right), of resting (R)
and HGHK-stimulated (S) INS-1 cells transfected with ICA512-RESP18-HD-GFP (n$3). The cell lysates were also immunoblotted forg-tubulin. (C and D) Schematic
drawings of ICA512-NTF-GFP and confocal microscopy images of resting INS-1 cells transfected with ICA512-NTF-GFP (green) and immunostained for insulin (C)
(red) or calnexin (D) (red) (n$ 3). Nuclei were labeled with DAPI (blue). Bars5 5 mm. (E) Immunoblotting for GFP (left) or NTF (right) in lysates of INS-1 cells
transfected with either CD33-GFP or ICA512-NTF-GFP (lanes 1 versus lanes 2) (n$ 3). (F) Schematic drawing of ICA512-NTF and confocal microscopy images of
INS-1 cells transfected with ICA512-NTF and immunostained for NTF (green) and calnexin (red) (n$ 3). Bars5 5mm.
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and RESP18-HD and their roles in SG biogenesis will be necessary
to elucidate the reasons for these phenomena.
Extending previous findings (17, 39, 40), we showed that N506
and N524 of ICA512 are both glycosylated (Fig. 3A and B). Lack of
glycosylation at these sites does not prevent targeting of
proICA512 to SGs (Fig. 3D) and its conversion to ICA512-TMF
(Fig. 3A). Simultaneous inhibition of N506 glycosylation and per-
turbation of the ME ICA512 b2-b2 association interface by re-
placement of S508A are also insufficient to prevent proICA512
conversion to ICA512-TMF (Fig. 3A) and ME ICA512-mediated
homodimerization (Fig. 8B). Conversely, perturbation of the ME
ICA512 b4-strand by G553D replacement hinders the stability,
SG targeting, and conversion of proICA512 (Fig. 4A to D), as well
as its recovery as a homodimer (Fig. 8B). On the other hand,
combined S508A/G553D or N506A/G553D replacements are still
compatible with proICA512 dimerization (Fig. 8B). A possible
explanation for the latter finding is that the extended b2-b2 asso-
ciation interface (19) (Fig. 1A and B) is sufficient for stable
proICA512 dimerization provided that glycosylation of N506, as
upon S508A replacement, is precluded. This conclusion is corrob-
orated by the greater yield of proICA512 homodimers recovered
when the G553D mutation is combined with the N506A replace-
ment, which structural studies predict to be less detrimental than
S508A replacement to ME ICA512 b2-b2 interface-mediated
dimerization (Fig. 8B and C). Notably, such b2-b2 interface-me-
diated proICA512 dimers are restricted to the ER, as indicated by
the endoglycosidase H sensitivity and lack of conversion of
proICA512-GFP S508A/G553D (Fig. 8D).
In conclusion, we propose a model whereby proICA512b2-b2
dimers prevail over b4-b4 dimers in the ER as long as the b2-
strand N506 is not glycosylated, possibly due to occlusion of this
region by NTF. Dislocation of NTF, as upon its binding to another
molecule, would allow for N506 glycosylation, thus irreversibly
shifting the equilibrium toward proICA512 b4-b4 dimers, conse-
quently allowing ICA512 to leave the ER (Fig. 8E). Importantly, this
model does not assume thatb4-b4 dimerizationper se is the signal for
ER export. Indeed, ICA512-GFP DNTF G553D, in which concomi-
tant glycosylation of N506 and G553D replacement should hinder
the formation of both ME ICA512 b2-b2 and b4-b4 dimers, is nev-
ertheless exported from the ER, conceivably as a monomer. Hence, it
is plausible that folding and/or homodimerization of ME ICA512
b4-strands are instrumental for stabilizing proICA512 and overcom-
ing the NTF ER retention signal.
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